PubMed Furuta T, Shirai N, Sugimoto M, Nakamura A, Hishida A, Ishizaki T
An estimated 3,160 participants are to receive once-weekly subcutaneous semaglutide (starting with 0.25 mg and the dose will be increased to 0.5 mg at 4 weeks and 1 mg at 8 weeks) for up to 5 years
They will assess your medical history and weight loss goals, then prescribe a compounded GLP-1 medication if appropriate, which will be prepared and delivered by a regulated compounding pharmacy
Certain individuals may be ineligible for tirzepatide treatment
Shelf Life for Opened, Sealed, Refrigerated and Mixed Vials BAC water is good for 28 days after opening and 2 to 3 years sealed
Semaglutide is not like the aspirin sitting in your medicine cabinet